Reckitt Benckiser Group plc (LON:RKT - Get Free Report) reached a new 52-week high on Thursday after Royal Bank Of Canada raised their price target on the stock from GBX 5,700 to GBX 6,000. Royal Bank Of Canada currently has an outperform rating on the stock. Reckitt Benckiser Group traded as high as GBX 5,610 ($75.38) and last traded at GBX 5,490 ($73.77), with a volume of 52624523 shares. The stock had previously closed at GBX 5,040 ($67.72).
Separately, Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a GBX 5,300 ($71.22) price objective on shares of Reckitt Benckiser Group in a research note on Monday, July 21st. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of GBX 5,219.25 ($70.13).
View Our Latest Stock Analysis on RKT
Reckitt Benckiser Group Price Performance
The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26. The business's fifty day moving average is GBX 5,047.51 and its 200 day moving average is GBX 5,061.56. The firm has a market capitalization of £38.37 billion, a P/E ratio of 25.74, a P/E/G ratio of 1.10 and a beta of 0.09.
Reckitt Benckiser Group (LON:RKT - Get Free Report) last announced its earnings results on Thursday, July 24th. The company reported GBX 141.20 ($1.90) EPS for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. As a group, analysts forecast that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current year.
About Reckitt Benckiser Group
(
Get Free Report)
At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we're all making a real difference to people all over the world, every day.
Featured Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.